Skip to main content
Clinical Trials/NCT00235378
NCT00235378
Completed
Not Applicable

Gene Mapping in Women With SLE

Oklahoma Medical Research Foundation1 site in 1 country2,356 target enrollmentJuly 1996

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Systemic Lupus Erythematosus
Sponsor
Oklahoma Medical Research Foundation
Enrollment
2356
Locations
1
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to perform genetic testing in and to collect information from families affected by lupus in order to identify the genetic factors associated with systemic lupus erythematosus (SLE).

Detailed Description

Little is known about the genetic factors that predispose people to developing SLE. Genes in patients with SLE may provide clues about SLE's pathogenesis. This study will compare genes from SLE patients, their unaffected family members, and control participants. Travel to the study site is not required. In this study, blood samples will be collected from people diagnosed with SLE, their unaffected family members, and condition-matched controls. Participants will be asked questions about their health and will provide a small blood sample. Participants will also be asked to provide written permission for release of medical information, so that their disease status can be verified through medical record review or through consultation with their doctors. Study personnel may contact participants in the future for follow-up questions and additional blood draws, if the participant agrees.

Registry
clinicaltrials.gov
Start Date
July 1996
End Date
March 2013
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of SLE OR a family member of participant diagnosed with SLE

Exclusion Criteria

  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials